nodes	percent_of_prediction	percent_of_DWPC	metapath
Etodolac—osteoarthritis—Methylprednisolone—ankylosing spondylitis	0.315	0.5	CpDpCtD
Etodolac—osteoarthritis—Prednisone—ankylosing spondylitis	0.315	0.5	CpDpCtD
Etodolac—PTGS2—Sulfasalazine—ankylosing spondylitis	0.0544	0.184	CbGbCtD
Etodolac—PTGS2—Triamcinolone—ankylosing spondylitis	0.0544	0.184	CbGbCtD
Etodolac—PTGS2—Betamethasone—ankylosing spondylitis	0.0467	0.158	CbGbCtD
Etodolac—PTGS1—Sulfasalazine—ankylosing spondylitis	0.046	0.156	CbGbCtD
Etodolac—ALB—Prednisone—ankylosing spondylitis	0.0275	0.0929	CbGbCtD
Etodolac—PTGS2—Dexamethasone—ankylosing spondylitis	0.0272	0.092	CbGbCtD
Etodolac—SLC22A6—Methotrexate—ankylosing spondylitis	0.0162	0.0547	CbGbCtD
Etodolac—ALB—Methotrexate—ankylosing spondylitis	0.0138	0.0466	CbGbCtD
Etodolac—CYP2C9—Dexamethasone—ankylosing spondylitis	0.00924	0.0313	CbGbCtD
Etodolac—PTGS2—Fluocinonide—Methylprednisolone—ankylosing spondylitis	0.000446	0.159	CbGdCrCtD
Etodolac—PTGS2—Fluocinonide—Dexamethasone—ankylosing spondylitis	0.000439	0.156	CbGdCrCtD
Etodolac—PTGS2—Fluocinonide—Betamethasone—ankylosing spondylitis	0.000439	0.156	CbGdCrCtD
Etodolac—PTGS2—Fluocinonide—Triamcinolone—ankylosing spondylitis	0.000428	0.153	CbGdCrCtD
Etodolac—PTGS2—Fluticasone Propionate—Methylprednisolone—ankylosing spondylitis	0.000269	0.0957	CbGdCrCtD
Etodolac—PTGS2—Fluticasone Propionate—Dexamethasone—ankylosing spondylitis	0.000265	0.0942	CbGdCrCtD
Etodolac—PTGS2—Fluticasone Propionate—Betamethasone—ankylosing spondylitis	0.000265	0.0942	CbGdCrCtD
Etodolac—PTGS2—Fluticasone Propionate—Triamcinolone—ankylosing spondylitis	0.000259	0.0921	CbGdCrCtD
Etodolac—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000123	0.00171	CcSEcCtD
Etodolac—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000123	0.00171	CcSEcCtD
Etodolac—Discomfort—Triamcinolone—ankylosing spondylitis	0.000123	0.00171	CcSEcCtD
Etodolac—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000122	0.0017	CcSEcCtD
Etodolac—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000122	0.0017	CcSEcCtD
Etodolac—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000121	0.00169	CcSEcCtD
Etodolac—Renal failure—Methotrexate—ankylosing spondylitis	0.000121	0.00169	CcSEcCtD
Etodolac—Angioedema—Dexamethasone—ankylosing spondylitis	0.000121	0.00168	CcSEcCtD
Etodolac—Angioedema—Betamethasone—ankylosing spondylitis	0.000121	0.00168	CcSEcCtD
Etodolac—Stomatitis—Methotrexate—ankylosing spondylitis	0.00012	0.00167	CcSEcCtD
Etodolac—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.00012	0.00167	CcSEcCtD
Etodolac—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00012	0.00167	CcSEcCtD
Etodolac—Malaise—Betamethasone—ankylosing spondylitis	0.000119	0.00166	CcSEcCtD
Etodolac—Malaise—Dexamethasone—ankylosing spondylitis	0.000119	0.00166	CcSEcCtD
Etodolac—Oedema—Triamcinolone—ankylosing spondylitis	0.000119	0.00166	CcSEcCtD
Etodolac—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000119	0.00166	CcSEcCtD
Etodolac—Vertigo—Betamethasone—ankylosing spondylitis	0.000119	0.00165	CcSEcCtD
Etodolac—Vertigo—Dexamethasone—ankylosing spondylitis	0.000119	0.00165	CcSEcCtD
Etodolac—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000119	0.00165	CcSEcCtD
Etodolac—Syncope—Dexamethasone—ankylosing spondylitis	0.000119	0.00165	CcSEcCtD
Etodolac—Syncope—Betamethasone—ankylosing spondylitis	0.000119	0.00165	CcSEcCtD
Etodolac—Arrhythmia—Prednisone—ankylosing spondylitis	0.000118	0.00164	CcSEcCtD
Etodolac—Infection—Triamcinolone—ankylosing spondylitis	0.000118	0.00164	CcSEcCtD
Etodolac—Sweating—Methotrexate—ankylosing spondylitis	0.000118	0.00164	CcSEcCtD
Etodolac—Infection—Methylprednisolone—ankylosing spondylitis	0.000118	0.00164	CcSEcCtD
Etodolac—Haematuria—Methotrexate—ankylosing spondylitis	0.000118	0.00163	CcSEcCtD
Etodolac—Shock—Triamcinolone—ankylosing spondylitis	0.000117	0.00163	CcSEcCtD
Etodolac—Insomnia—Prednisolone—ankylosing spondylitis	0.000117	0.00163	CcSEcCtD
Etodolac—Alopecia—Prednisone—ankylosing spondylitis	0.000117	0.00163	CcSEcCtD
Etodolac—Shock—Methylprednisolone—ankylosing spondylitis	0.000117	0.00163	CcSEcCtD
Etodolac—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000116	0.00162	CcSEcCtD
Etodolac—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000116	0.00162	CcSEcCtD
Etodolac—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000116	0.00162	CcSEcCtD
Etodolac—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000116	0.00162	CcSEcCtD
Etodolac—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000116	0.00161	CcSEcCtD
Etodolac—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000115	0.0016	CcSEcCtD
Etodolac—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000115	0.0016	CcSEcCtD
Etodolac—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000115	0.0016	CcSEcCtD
Etodolac—Convulsion—Betamethasone—ankylosing spondylitis	0.000115	0.00159	CcSEcCtD
Etodolac—Convulsion—Dexamethasone—ankylosing spondylitis	0.000115	0.00159	CcSEcCtD
Etodolac—Hypertension—Dexamethasone—ankylosing spondylitis	0.000114	0.00159	CcSEcCtD
Etodolac—Hypertension—Betamethasone—ankylosing spondylitis	0.000114	0.00159	CcSEcCtD
Etodolac—Myalgia—Betamethasone—ankylosing spondylitis	0.000113	0.00157	CcSEcCtD
Etodolac—Myalgia—Dexamethasone—ankylosing spondylitis	0.000113	0.00157	CcSEcCtD
Etodolac—Anxiety—Betamethasone—ankylosing spondylitis	0.000112	0.00156	CcSEcCtD
Etodolac—Anxiety—Dexamethasone—ankylosing spondylitis	0.000112	0.00156	CcSEcCtD
Etodolac—Discomfort—Dexamethasone—ankylosing spondylitis	0.000111	0.00155	CcSEcCtD
Etodolac—Discomfort—Betamethasone—ankylosing spondylitis	0.000111	0.00155	CcSEcCtD
Etodolac—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000111	0.00155	CcSEcCtD
Etodolac—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000111	0.00154	CcSEcCtD
Etodolac—Pain—Prednisolone—ankylosing spondylitis	0.000111	0.00154	CcSEcCtD
Etodolac—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000111	0.00154	CcSEcCtD
Etodolac—Hepatitis—Methotrexate—ankylosing spondylitis	0.000111	0.00154	CcSEcCtD
Etodolac—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00011	0.00153	CcSEcCtD
Etodolac—Vision blurred—Prednisone—ankylosing spondylitis	0.000109	0.00151	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000108	0.00151	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000108	0.0015	CcSEcCtD
Etodolac—Oedema—Betamethasone—ankylosing spondylitis	0.000108	0.0015	CcSEcCtD
Etodolac—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000108	0.0015	CcSEcCtD
Etodolac—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000108	0.0015	CcSEcCtD
Etodolac—Oedema—Dexamethasone—ankylosing spondylitis	0.000108	0.0015	CcSEcCtD
Etodolac—Insomnia—Triamcinolone—ankylosing spondylitis	0.000108	0.0015	CcSEcCtD
Etodolac—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000107	0.00149	CcSEcCtD
Etodolac—Infection—Dexamethasone—ankylosing spondylitis	0.000107	0.00149	CcSEcCtD
Etodolac—Infection—Betamethasone—ankylosing spondylitis	0.000107	0.00149	CcSEcCtD
Etodolac—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000107	0.00149	CcSEcCtD
Etodolac—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000107	0.00149	CcSEcCtD
Etodolac—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000107	0.00148	CcSEcCtD
Etodolac—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000107	0.00148	CcSEcCtD
Etodolac—Visual impairment—Methotrexate—ankylosing spondylitis	0.000107	0.00148	CcSEcCtD
Etodolac—Anaemia—Prednisone—ankylosing spondylitis	0.000107	0.00148	CcSEcCtD
Etodolac—Shock—Betamethasone—ankylosing spondylitis	0.000106	0.00148	CcSEcCtD
Etodolac—Shock—Dexamethasone—ankylosing spondylitis	0.000106	0.00148	CcSEcCtD
Etodolac—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000106	0.00148	CcSEcCtD
Etodolac—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000106	0.00147	CcSEcCtD
Etodolac—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000106	0.00147	CcSEcCtD
Etodolac—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000105	0.00147	CcSEcCtD
Etodolac—Tachycardia—Betamethasone—ankylosing spondylitis	0.000105	0.00147	CcSEcCtD
Etodolac—Angioedema—Prednisone—ankylosing spondylitis	0.000105	0.00146	CcSEcCtD
Etodolac—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000105	0.00146	CcSEcCtD
Etodolac—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000105	0.00146	CcSEcCtD
Etodolac—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000105	0.00145	CcSEcCtD
Etodolac—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000104	0.00145	CcSEcCtD
Etodolac—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000104	0.00145	CcSEcCtD
Etodolac—Malaise—Prednisone—ankylosing spondylitis	0.000104	0.00145	CcSEcCtD
Etodolac—Vertigo—Prednisone—ankylosing spondylitis	0.000104	0.00144	CcSEcCtD
Etodolac—Syncope—Prednisone—ankylosing spondylitis	0.000103	0.00144	CcSEcCtD
Etodolac—Tinnitus—Methotrexate—ankylosing spondylitis	0.000103	0.00143	CcSEcCtD
Etodolac—Anorexia—Dexamethasone—ankylosing spondylitis	0.000103	0.00143	CcSEcCtD
Etodolac—Anorexia—Betamethasone—ankylosing spondylitis	0.000103	0.00143	CcSEcCtD
Etodolac—Urticaria—Prednisolone—ankylosing spondylitis	0.000103	0.00143	CcSEcCtD
Etodolac—Fatigue—Triamcinolone—ankylosing spondylitis	0.000103	0.00143	CcSEcCtD
Etodolac—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000102	0.00142	CcSEcCtD
Etodolac—Pain—Triamcinolone—ankylosing spondylitis	0.000102	0.00142	CcSEcCtD
Etodolac—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000101	0.00141	CcSEcCtD
Etodolac—Hypotension—Betamethasone—ankylosing spondylitis	0.000101	0.0014	CcSEcCtD
Etodolac—Hypotension—Dexamethasone—ankylosing spondylitis	0.000101	0.0014	CcSEcCtD
Etodolac—Convulsion—Prednisone—ankylosing spondylitis	9.99e-05	0.00139	CcSEcCtD
Etodolac—Hypertension—Prednisone—ankylosing spondylitis	9.95e-05	0.00138	CcSEcCtD
Etodolac—Chills—Methotrexate—ankylosing spondylitis	9.93e-05	0.00138	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	9.84e-05	0.00137	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	9.84e-05	0.00137	CcSEcCtD
Etodolac—Myalgia—Prednisone—ankylosing spondylitis	9.81e-05	0.00136	CcSEcCtD
Etodolac—Arthralgia—Prednisone—ankylosing spondylitis	9.81e-05	0.00136	CcSEcCtD
Etodolac—Feeling abnormal—Triamcinolone—ankylosing spondylitis	9.81e-05	0.00136	CcSEcCtD
Etodolac—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	9.79e-05	0.00136	CcSEcCtD
Etodolac—Anxiety—Prednisone—ankylosing spondylitis	9.78e-05	0.00136	CcSEcCtD
Etodolac—Alopecia—Methotrexate—ankylosing spondylitis	9.78e-05	0.00136	CcSEcCtD
Etodolac—Insomnia—Betamethasone—ankylosing spondylitis	9.77e-05	0.00136	CcSEcCtD
Etodolac—Insomnia—Dexamethasone—ankylosing spondylitis	9.77e-05	0.00136	CcSEcCtD
Etodolac—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	9.71e-05	0.00135	CcSEcCtD
Etodolac—Paraesthesia—Betamethasone—ankylosing spondylitis	9.7e-05	0.00135	CcSEcCtD
Etodolac—Paraesthesia—Dexamethasone—ankylosing spondylitis	9.7e-05	0.00135	CcSEcCtD
Etodolac—Discomfort—Prednisone—ankylosing spondylitis	9.7e-05	0.00135	CcSEcCtD
Etodolac—Hypersensitivity—Prednisolone—ankylosing spondylitis	9.54e-05	0.00133	CcSEcCtD
Etodolac—Dyspepsia—Betamethasone—ankylosing spondylitis	9.51e-05	0.00132	CcSEcCtD
Etodolac—Dyspepsia—Dexamethasone—ankylosing spondylitis	9.51e-05	0.00132	CcSEcCtD
Etodolac—Urticaria—Triamcinolone—ankylosing spondylitis	9.46e-05	0.00132	CcSEcCtD
Etodolac—Urticaria—Methylprednisolone—ankylosing spondylitis	9.44e-05	0.00131	CcSEcCtD
Etodolac—Dysgeusia—Methotrexate—ankylosing spondylitis	9.43e-05	0.00131	CcSEcCtD
Etodolac—Body temperature increased—Triamcinolone—ankylosing spondylitis	9.41e-05	0.00131	CcSEcCtD
Etodolac—Oedema—Prednisone—ankylosing spondylitis	9.41e-05	0.00131	CcSEcCtD
Etodolac—Anaphylactic shock—Prednisone—ankylosing spondylitis	9.41e-05	0.00131	CcSEcCtD
Etodolac—Abdominal pain—Methylprednisolone—ankylosing spondylitis	9.39e-05	0.00131	CcSEcCtD
Etodolac—Decreased appetite—Betamethasone—ankylosing spondylitis	9.39e-05	0.00131	CcSEcCtD
Etodolac—Decreased appetite—Dexamethasone—ankylosing spondylitis	9.39e-05	0.00131	CcSEcCtD
Etodolac—Infection—Prednisone—ankylosing spondylitis	9.35e-05	0.0013	CcSEcCtD
Etodolac—Fatigue—Dexamethasone—ankylosing spondylitis	9.31e-05	0.0013	CcSEcCtD
Etodolac—Fatigue—Betamethasone—ankylosing spondylitis	9.31e-05	0.0013	CcSEcCtD
Etodolac—Shock—Prednisone—ankylosing spondylitis	9.26e-05	0.00129	CcSEcCtD
Etodolac—Pain—Betamethasone—ankylosing spondylitis	9.24e-05	0.00128	CcSEcCtD
Etodolac—Pain—Dexamethasone—ankylosing spondylitis	9.24e-05	0.00128	CcSEcCtD
Etodolac—Tachycardia—Prednisone—ankylosing spondylitis	9.18e-05	0.00128	CcSEcCtD
Etodolac—Hyperhidrosis—Prednisone—ankylosing spondylitis	9.09e-05	0.00126	CcSEcCtD
Etodolac—Vision blurred—Methotrexate—ankylosing spondylitis	9.08e-05	0.00126	CcSEcCtD
Etodolac—Anorexia—Prednisone—ankylosing spondylitis	8.97e-05	0.00125	CcSEcCtD
Etodolac—Ill-defined disorder—Methotrexate—ankylosing spondylitis	8.94e-05	0.00124	CcSEcCtD
Etodolac—Anaemia—Methotrexate—ankylosing spondylitis	8.9e-05	0.00124	CcSEcCtD
Etodolac—Feeling abnormal—Dexamethasone—ankylosing spondylitis	8.9e-05	0.00124	CcSEcCtD
Etodolac—Feeling abnormal—Betamethasone—ankylosing spondylitis	8.9e-05	0.00124	CcSEcCtD
Etodolac—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	8.83e-05	0.00123	CcSEcCtD
Etodolac—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	8.83e-05	0.00123	CcSEcCtD
Etodolac—Hypersensitivity—Triamcinolone—ankylosing spondylitis	8.77e-05	0.00122	CcSEcCtD
Etodolac—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	8.75e-05	0.00122	CcSEcCtD
Etodolac—Malaise—Methotrexate—ankylosing spondylitis	8.69e-05	0.00121	CcSEcCtD
Etodolac—Vertigo—Methotrexate—ankylosing spondylitis	8.65e-05	0.0012	CcSEcCtD
Etodolac—Leukopenia—Methotrexate—ankylosing spondylitis	8.62e-05	0.0012	CcSEcCtD
Etodolac—Urticaria—Dexamethasone—ankylosing spondylitis	8.58e-05	0.00119	CcSEcCtD
Etodolac—Urticaria—Betamethasone—ankylosing spondylitis	8.58e-05	0.00119	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	8.57e-05	0.00119	CcSEcCtD
Etodolac—Dizziness—Prednisolone—ankylosing spondylitis	8.56e-05	0.00119	CcSEcCtD
Etodolac—Asthenia—Triamcinolone—ankylosing spondylitis	8.54e-05	0.00119	CcSEcCtD
Etodolac—Body temperature increased—Dexamethasone—ankylosing spondylitis	8.54e-05	0.00119	CcSEcCtD
Etodolac—Body temperature increased—Betamethasone—ankylosing spondylitis	8.54e-05	0.00119	CcSEcCtD
Etodolac—Abdominal pain—Betamethasone—ankylosing spondylitis	8.54e-05	0.00119	CcSEcCtD
Etodolac—Abdominal pain—Dexamethasone—ankylosing spondylitis	8.54e-05	0.00119	CcSEcCtD
Etodolac—Asthenia—Methylprednisolone—ankylosing spondylitis	8.52e-05	0.00119	CcSEcCtD
Etodolac—Insomnia—Prednisone—ankylosing spondylitis	8.51e-05	0.00118	CcSEcCtD
Etodolac—Paraesthesia—Prednisone—ankylosing spondylitis	8.45e-05	0.00117	CcSEcCtD
Etodolac—Pruritus—Triamcinolone—ankylosing spondylitis	8.42e-05	0.00117	CcSEcCtD
Etodolac—Pruritus—Methylprednisolone—ankylosing spondylitis	8.4e-05	0.00117	CcSEcCtD
Etodolac—Convulsion—Methotrexate—ankylosing spondylitis	8.35e-05	0.00116	CcSEcCtD
Etodolac—Dyspepsia—Prednisone—ankylosing spondylitis	8.28e-05	0.00115	CcSEcCtD
Etodolac—Arthralgia—Methotrexate—ankylosing spondylitis	8.2e-05	0.00114	CcSEcCtD
Etodolac—Myalgia—Methotrexate—ankylosing spondylitis	8.2e-05	0.00114	CcSEcCtD
Etodolac—Decreased appetite—Prednisone—ankylosing spondylitis	8.18e-05	0.00114	CcSEcCtD
Etodolac—Rash—Prednisolone—ankylosing spondylitis	8.16e-05	0.00114	CcSEcCtD
Etodolac—Dermatitis—Prednisolone—ankylosing spondylitis	8.16e-05	0.00113	CcSEcCtD
Etodolac—Diarrhoea—Methylprednisolone—ankylosing spondylitis	8.13e-05	0.00113	CcSEcCtD
Etodolac—Fatigue—Prednisone—ankylosing spondylitis	8.11e-05	0.00113	CcSEcCtD
Etodolac—Headache—Prednisolone—ankylosing spondylitis	8.11e-05	0.00113	CcSEcCtD
Etodolac—Discomfort—Methotrexate—ankylosing spondylitis	8.1e-05	0.00113	CcSEcCtD
Etodolac—Constipation—Prednisone—ankylosing spondylitis	8.04e-05	0.00112	CcSEcCtD
Etodolac—Confusional state—Methotrexate—ankylosing spondylitis	7.93e-05	0.0011	CcSEcCtD
Etodolac—Dizziness—Triamcinolone—ankylosing spondylitis	7.87e-05	0.00109	CcSEcCtD
Etodolac—Anaphylactic shock—Methotrexate—ankylosing spondylitis	7.86e-05	0.00109	CcSEcCtD
Etodolac—Dizziness—Methylprednisolone—ankylosing spondylitis	7.86e-05	0.00109	CcSEcCtD
Etodolac—Infection—Methotrexate—ankylosing spondylitis	7.81e-05	0.00109	CcSEcCtD
Etodolac—Feeling abnormal—Prednisone—ankylosing spondylitis	7.75e-05	0.00108	CcSEcCtD
Etodolac—Asthenia—Dexamethasone—ankylosing spondylitis	7.75e-05	0.00108	CcSEcCtD
Etodolac—Asthenia—Betamethasone—ankylosing spondylitis	7.75e-05	0.00108	CcSEcCtD
Etodolac—Thrombocytopenia—Methotrexate—ankylosing spondylitis	7.7e-05	0.00107	CcSEcCtD
Etodolac—Gastrointestinal pain—Prednisone—ankylosing spondylitis	7.69e-05	0.00107	CcSEcCtD
Etodolac—Nausea—Prednisolone—ankylosing spondylitis	7.69e-05	0.00107	CcSEcCtD
Etodolac—Pruritus—Dexamethasone—ankylosing spondylitis	7.64e-05	0.00106	CcSEcCtD
Etodolac—Pruritus—Betamethasone—ankylosing spondylitis	7.64e-05	0.00106	CcSEcCtD
Etodolac—Hyperhidrosis—Methotrexate—ankylosing spondylitis	7.6e-05	0.00106	CcSEcCtD
Etodolac—Vomiting—Triamcinolone—ankylosing spondylitis	7.57e-05	0.00105	CcSEcCtD
Etodolac—Vomiting—Methylprednisolone—ankylosing spondylitis	7.55e-05	0.00105	CcSEcCtD
Etodolac—Rash—Triamcinolone—ankylosing spondylitis	7.51e-05	0.00104	CcSEcCtD
Etodolac—Dermatitis—Triamcinolone—ankylosing spondylitis	7.5e-05	0.00104	CcSEcCtD
Etodolac—Anorexia—Methotrexate—ankylosing spondylitis	7.49e-05	0.00104	CcSEcCtD
Etodolac—Rash—Methylprednisolone—ankylosing spondylitis	7.49e-05	0.00104	CcSEcCtD
Etodolac—Dermatitis—Methylprednisolone—ankylosing spondylitis	7.48e-05	0.00104	CcSEcCtD
Etodolac—Urticaria—Prednisone—ankylosing spondylitis	7.47e-05	0.00104	CcSEcCtD
Etodolac—Headache—Triamcinolone—ankylosing spondylitis	7.46e-05	0.00104	CcSEcCtD
Etodolac—Headache—Methylprednisolone—ankylosing spondylitis	7.44e-05	0.00103	CcSEcCtD
Etodolac—Abdominal pain—Prednisone—ankylosing spondylitis	7.44e-05	0.00103	CcSEcCtD
Etodolac—Body temperature increased—Prednisone—ankylosing spondylitis	7.44e-05	0.00103	CcSEcCtD
Etodolac—Diarrhoea—Betamethasone—ankylosing spondylitis	7.39e-05	0.00103	CcSEcCtD
Etodolac—Diarrhoea—Dexamethasone—ankylosing spondylitis	7.39e-05	0.00103	CcSEcCtD
Etodolac—Hypotension—Methotrexate—ankylosing spondylitis	7.35e-05	0.00102	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	7.16e-05	0.000996	CcSEcCtD
Etodolac—Dizziness—Dexamethasone—ankylosing spondylitis	7.14e-05	0.000993	CcSEcCtD
Etodolac—Dizziness—Betamethasone—ankylosing spondylitis	7.14e-05	0.000993	CcSEcCtD
Etodolac—Insomnia—Methotrexate—ankylosing spondylitis	7.11e-05	0.000989	CcSEcCtD
Etodolac—Nausea—Triamcinolone—ankylosing spondylitis	7.07e-05	0.000983	CcSEcCtD
Etodolac—Paraesthesia—Methotrexate—ankylosing spondylitis	7.06e-05	0.000982	CcSEcCtD
Etodolac—Nausea—Methylprednisolone—ankylosing spondylitis	7.06e-05	0.000981	CcSEcCtD
Etodolac—Dyspnoea—Methotrexate—ankylosing spondylitis	7.01e-05	0.000975	CcSEcCtD
Etodolac—Somnolence—Methotrexate—ankylosing spondylitis	6.99e-05	0.000972	CcSEcCtD
Etodolac—Hypersensitivity—Prednisone—ankylosing spondylitis	6.93e-05	0.000964	CcSEcCtD
Etodolac—Dyspepsia—Methotrexate—ankylosing spondylitis	6.92e-05	0.000962	CcSEcCtD
Etodolac—Vomiting—Dexamethasone—ankylosing spondylitis	6.87e-05	0.000955	CcSEcCtD
Etodolac—Vomiting—Betamethasone—ankylosing spondylitis	6.87e-05	0.000955	CcSEcCtD
Etodolac—Decreased appetite—Methotrexate—ankylosing spondylitis	6.83e-05	0.00095	CcSEcCtD
Etodolac—Rash—Dexamethasone—ankylosing spondylitis	6.81e-05	0.000947	CcSEcCtD
Etodolac—Rash—Betamethasone—ankylosing spondylitis	6.81e-05	0.000947	CcSEcCtD
Etodolac—Dermatitis—Betamethasone—ankylosing spondylitis	6.8e-05	0.000946	CcSEcCtD
Etodolac—Dermatitis—Dexamethasone—ankylosing spondylitis	6.8e-05	0.000946	CcSEcCtD
Etodolac—Fatigue—Methotrexate—ankylosing spondylitis	6.78e-05	0.000943	CcSEcCtD
Etodolac—Headache—Dexamethasone—ankylosing spondylitis	6.77e-05	0.000941	CcSEcCtD
Etodolac—Headache—Betamethasone—ankylosing spondylitis	6.77e-05	0.000941	CcSEcCtD
Etodolac—Asthenia—Prednisone—ankylosing spondylitis	6.75e-05	0.000939	CcSEcCtD
Etodolac—Pain—Methotrexate—ankylosing spondylitis	6.72e-05	0.000935	CcSEcCtD
Etodolac—Pruritus—Prednisone—ankylosing spondylitis	6.66e-05	0.000926	CcSEcCtD
Etodolac—Feeling abnormal—Methotrexate—ankylosing spondylitis	6.48e-05	0.000901	CcSEcCtD
Etodolac—Diarrhoea—Prednisone—ankylosing spondylitis	6.44e-05	0.000895	CcSEcCtD
Etodolac—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	6.43e-05	0.000894	CcSEcCtD
Etodolac—Nausea—Betamethasone—ankylosing spondylitis	6.42e-05	0.000892	CcSEcCtD
Etodolac—Nausea—Dexamethasone—ankylosing spondylitis	6.42e-05	0.000892	CcSEcCtD
Etodolac—Urticaria—Methotrexate—ankylosing spondylitis	6.25e-05	0.000869	CcSEcCtD
Etodolac—Dizziness—Prednisone—ankylosing spondylitis	6.22e-05	0.000865	CcSEcCtD
Etodolac—Body temperature increased—Methotrexate—ankylosing spondylitis	6.22e-05	0.000864	CcSEcCtD
Etodolac—Abdominal pain—Methotrexate—ankylosing spondylitis	6.22e-05	0.000864	CcSEcCtD
Etodolac—Vomiting—Prednisone—ankylosing spondylitis	5.98e-05	0.000832	CcSEcCtD
Etodolac—Rash—Prednisone—ankylosing spondylitis	5.93e-05	0.000825	CcSEcCtD
Etodolac—Dermatitis—Prednisone—ankylosing spondylitis	5.93e-05	0.000824	CcSEcCtD
Etodolac—Headache—Prednisone—ankylosing spondylitis	5.89e-05	0.00082	CcSEcCtD
Etodolac—Hypersensitivity—Methotrexate—ankylosing spondylitis	5.79e-05	0.000805	CcSEcCtD
Etodolac—Asthenia—Methotrexate—ankylosing spondylitis	5.64e-05	0.000784	CcSEcCtD
Etodolac—Nausea—Prednisone—ankylosing spondylitis	5.59e-05	0.000777	CcSEcCtD
Etodolac—Pruritus—Methotrexate—ankylosing spondylitis	5.56e-05	0.000774	CcSEcCtD
Etodolac—Diarrhoea—Methotrexate—ankylosing spondylitis	5.38e-05	0.000748	CcSEcCtD
Etodolac—Dizziness—Methotrexate—ankylosing spondylitis	5.2e-05	0.000723	CcSEcCtD
Etodolac—Vomiting—Methotrexate—ankylosing spondylitis	5e-05	0.000695	CcSEcCtD
Etodolac—Rash—Methotrexate—ankylosing spondylitis	4.96e-05	0.000689	CcSEcCtD
Etodolac—Dermatitis—Methotrexate—ankylosing spondylitis	4.95e-05	0.000689	CcSEcCtD
Etodolac—Headache—Methotrexate—ankylosing spondylitis	4.93e-05	0.000685	CcSEcCtD
Etodolac—Nausea—Methotrexate—ankylosing spondylitis	4.67e-05	0.000649	CcSEcCtD
